Literature DB >> 12003705

Resistant hypertension.

David A Calhoun1, Mohammad A Zaman, Mari K Nishizaka.   

Abstract

Recent clinical trials suggest that resistant hypertension is increasingly common. In the majority of patients, uncontrolled hypertension is due to persistent elevation of the systolic blood pressure. Older age and obesity are associated with poor blood pressure control. Other contributing factors include severity of the underlying hypertension and renal insufficiency. Poor patient adherence is thought be a common cause of medication resistance. Exogenous substances such as nonsteroidal anti-inflammatory drugs, oral contraceptives, and sympathomimetic agents can interfere with treatment. The prevalence of secondary causes of hypertension increases with age, especially atherosclerotic renal artery stenosis. Recent reports suggest that primary aldosteronism may be the most common secondary cause of hypertension. It should be considered in all patients with resistant hypertension. Effective treatment of resistant hypertension requires identification and reversal of contributing factors and/or secondary causes of hypertension. Pharmacologic therapy should utilize combination therapy, including a long-acting diuretic.

Entities:  

Mesh:

Year:  2002        PMID: 12003705     DOI: 10.1007/s11906-002-0011-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  49 in total

1.  Characteristics of patients with uncontrolled hypertension in the United States.

Authors:  D J Hyman; V N Pavlik
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  How common is white coat hypertension?

Authors:  T G Pickering; G D James; C Boddie; G A Harshfield; S Blank; J H Laragh
Journal:  JAMA       Date:  1988-01-08       Impact factor: 56.272

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

5.  Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; E J Roccella; D Levy
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

6.  Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.

Authors:  A G Johnson; T V Nguyen; R O Day
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

7.  White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study.

Authors:  P Palatini; F Dorigatti; E Roman; P Giovinazzo; D Piccolo; G De Venuto; M Mattarei; E Cozzutti; S Gregori; P Mormino; A C Pessina
Journal:  J Hypertens       Date:  1998-07       Impact factor: 4.844

8.  Screening for noncompliance among patients with hypertension: is self-report the best available measure?

Authors:  T S Inui; W B Carter; R E Pecoraro
Journal:  Med Care       Date:  1981-10       Impact factor: 2.983

Review 9.  Salt sensitivity of blood pressure in humans.

Authors:  M H Weinberger
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

10.  Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group.

Authors:  P Elliott; J Stamler; R Nichols; A R Dyer; R Stamler; H Kesteloot; M Marmot
Journal:  BMJ       Date:  1996-05-18
View more
  10 in total

1.  Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system.

Authors:  John J Sim; Simran K Bhandari; Jiaxiao Shi; In Lu A Liu; David A Calhoun; Elizabeth A McGlynn; Kamyar Kalantar-Zadeh; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2013-10       Impact factor: 7.616

Review 2.  Role of voltage-gated calcium channels in the regulation of aldosterone production from zona glomerulosa cells of the adrenal cortex.

Authors:  Paula Q Barrett; Nick A Guagliardo; Peter M Klein; Changlong Hu; David T Breault; Mark P Beenhakker
Journal:  J Physiol       Date:  2016-03-04       Impact factor: 5.182

Review 3.  Yoga for essential hypertension: a systematic review.

Authors:  Jie Wang; Xingjiang Xiong; Wei Liu
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

4.  The Relationship between Dietary Patterns with Blood Pressure in Iranian Army Staffs.

Authors:  Arasb Dabbagh-Moghaddam; Majid Kamali; Atefeh Hojjati; Mehdi Foroughi; Reza Ghiasvand; Gholamreza Askari; Javad Hosseinzadeh
Journal:  Adv Biomed Res       Date:  2018-09-21

5.  Retinoic acid receptor α as a novel contributor to adrenal cortex structure and function through interactions with Wnt and Vegfa signalling.

Authors:  Rami M El Zein; Audrey H Soria; Jose Felipe Golib Dzib; Amanda J Rickard; Fabio L Fernandes-Rosa; Benoit Samson-Couterie; Isabelle Giscos-Douriez; Angélique Rocha; Marko Poglitsch; Celso E Gomez-Sanchez; Laurence Amar; Norbert B Ghyselinck; Arndt Benecke; Maria-Christina Zennaro; Sheerazed Boulkroun
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

6.  Erectile dysfunction among hypertensive men in a rapidly developing country.

Authors:  Abdulbari Bener; Abdullah Al-Ansari; Mustafa Afifi; Prasad V Krishna
Journal:  Indian J Urol       Date:  2007-04

7.  Evaluation and treatment of resistant or difficult-to-control hypertension.

Authors:  David Wojciechowski; Vasilios Papademetriou; Charles Faselis; Ross Fletcher
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-11       Impact factor: 3.738

Review 8.  State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension.

Authors:  Pantelis A Sarafidis; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-02       Impact factor: 3.738

Review 9.  Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients.

Authors:  Jie Wang; Xingjiang Xiong; Wei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-10       Impact factor: 2.629

10.  Effect of low-dose spironolactone on resistant hypertension in type 2 diabetes mellitus: a randomized controlled trial in a sub-Saharan African population.

Authors:  Romance Nguetse Djoumessi; Jean Jacques N Noubiap; Francois Folefack Kaze; Mickael Essouma; Alain Patrick Menanga; Andre Pascal Kengne; Jean Claude Mbanya; Eugene Sobngwi
Journal:  BMC Res Notes       Date:  2016-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.